A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT
Clinical trial NCT04995653 · COMPLETED
Trial details
- NCT number
- NCT04995653
- Sponsor
- Seres Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2024-07-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.